NASDAQ
Edgewise Therapeutics, Inc. (EWTX) has a current ratio of 19.85x as of Monday, May 25, 2026. This represents a 9.68% decrease compared to its 12-month average of 21.98x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.